The global anti-ageing drugs market is anticipated to grow at a considerable CAGR of 7.1% during the forecast period. The increasing demand for non-surgical procedures is the major factor responsible for driving the growth of the anti-ageing drugs market over the forecast period. According to the International Society of Aesthetic Plastic Surgery (ISAPS), as of 2020, total non-surgical procedures increased by 5.7% and total surgical procedures decreased by 10.9%. Non-surgical procedures such as injection of filler materials under the skin can fill in deep folds, including nasolabial folds, create fuller lips and build up hollow cheeks and eyes. Injectables such as dermal fillers, muscle relaxers, liquid facelifts, and others can change the facial profile by smoothing and tightening the skin.
Browse the full report description “Global Anti-Ageing Drugs Market Size, Share & Trends Analysis Report by Drug Class (Antioxidants and Enzymes, Serums and Supplements, Stem Cells, and Others), by Type (Injectable, Oral, and Topical), and by Application (Skin, Hair, Muscles, Age-Related Disorders, and Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/anti-ageing-drugs-market
While collagen is the standard filler, hyaluronic acid fillers are now becoming more popular. Key market players in the industry are putting a lot of effort into significantly reducing and reversing the effects of ageing through non-surgical aesthetic treatment that stimulates the body to increase its production of collagen in the skin. For instance, in April 2022, Allergan Aesthetics, an AbbVie Co., announced its entry into the category of Hybrid Injectables with the launch of HArmonyCa with Lidocaine. This is THE company’s first dual-effect product, which combines the two active ingredients - hyaluronic acid (HA) and calcium hydroxyapatite (CaHA) - in one injection. The treatment offers immediate lift and the CaHA causES new collagen production.
Furthermore, several advancements in medical science and the introduction of new non-surgical anti-ageing treatments and products are some of the major factors which are anticipated to bolster the growth of anti-ageing drugs market over the forecast period.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- Allergan plc, Daewoong Pharmaceutical Co., Ltd., Elysium Health, Inc., Galderma SA, MerzPharma Canada Ltd., and others.
Key questions addressed by the report
oDeviation from the pre-COVID-19 forecast
oMost affected region and segment
Global Anti-Ageing Drugs Market Report Segment
By Drug Class
By Type
By Application
Global Anti-Ageing DrugsMarket Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/anti-ageing-drugs-market